GEN Exclusives

Modifications to Histones Affect Gene Expression and Cell Fate Decisions

Predictions for 2017

Old Becomes Fresh Again

Proteases in Some Cancer Cells Have the Capability to Break Antibodies by Taking Them Off Their Hinges

GEN News Highlights

Novartis’ Kymriah Wins FDA Approval as Very first CAR-T Cancer Therapy

The FDA today approved Novartis` Kymriah (tisagenlecleucel), with the agency hailing the chimeric antigen receptor T-cell (CAR-T) treatment as the very first gene therapy to be available in the U.S. Contine reading →